Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03370536 · ClinicalTrials.gov registry record · NA
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
A NA study, sponsored by Vivek Reddy.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03370536: Clinical Trial NA study, sponsored by Vivek Reddy.
NCT03370536 is a NA study that was terminated before completion, run by Vivek Reddy. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03370536, a NA study, was terminated before completion, sponsored by Vivek Reddy.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized, un-blinded, observational trial.
Primary Outcome
Freedom from recurrent At/AF
Interventions
- DRUG Ibutilide
- DEVICE CardioInsight ECGI Mapping System
- PROCEDURE AF ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2018-07-18 |
| Phase | NA |
Why NCT03370536 stopped before completion
NCT03370536 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Ibutilide is the first listed.
NCT03370536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03370536 about?
NCT03370536 is a clinical study titled "ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization". This is a prospective, multi-center, non-randomized, un-blinded, observational trial.
What is the current status of trial NCT03370536?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-11-01. Estimated completion is 2018-07-18.
What interventions are being tested in trial NCT03370536?
The interventions under investigation include: Ibutilide (DRUG), CardioInsight ECGI Mapping System (DEVICE), AF ablation (PROCEDURE).
Who is sponsoring clinical trial NCT03370536?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03370536's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI